Literature DB >> 4129823

Persistence of hapten-antibody complexes in the circulation of immunized animals after a single intravenous injection of hapten.

D H Schmidt, B M Kaufman, V P Butler.   

Abstract

To study the fate of a low molecular weight antigen (hapten) in the circulation of animals whose sera contain antibodies specific for that low molecular weight antigen, a single injection of digoxin-(3)H (0.4 mg/kg) was administered intravenously to 18 rabbits. Thirteen animals (nine nonimmunized and four immunized with bovine serum albumin) served as control animals. In five rabbits which had been immunized with a digoxin-bovine serum albumin conjugate and whose sera contained digoxin-specific antibodies, the mean 12-h serum digoxin concentration was 8,300 ng/ml (control: 92 ng/ml) and the mean serum concentration 12 mo after the single injection of digoxin-(3)H was 85 ng/ml. In digoxin-immunized rabbits, less than 10% of the digoxin-(3)H was excreted in the first 10 days (control: 77% recovered in urine and feces) and the mean biological half-life of digoxin, as calculated from serum digoxin-(3)H disappearance curves, was 72 days (control: 3.4 days). In sera of digoxin-immunized rabbits, more than 90% of the circulating digoxin-(3)H was immunoglobulin bound, as determined by the double-antibody and dextran-coated charcoal methods. The serum disappearance rate of (125)I-antidigoxin antibodies was similar in nonimmunized and in immunized animals and in the presence or absence of digoxin. It is concluded that the biological half-life of a hapten may be markedly prolonged when the hapten is bound to specific antibody. The persistence of antibody-hapten complexes in the circulation suggests that these complexes may not be deposited in tissues and raises the possibility that low molecular weight determinants may be capable of preventing or reversing the deposition of immune complexes, containing macromolecular antigens, in the tissues of experimental animals and man.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4129823      PMCID: PMC2139521          DOI: 10.1084/jem.139.2.278

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  HEMAGGLUTINATION BY RHEUMATOID FACTOR OF CELLS COATED WITH ANIMAL GAMMA GLOBULINS.

Authors:  V P BUTLER; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1964-07

2.  The serum proteins in multiple myelomatosis.

Authors:  R A Kekwick
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

3.  Fate of antibody following in vivo combination with specific antigen.

Authors:  F J DIXON; P H MAURER
Journal:  Proc Soc Exp Biol Med       Date:  1953-11

4.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

5.  The effect of antigen excess on chronic immune complex glomerulonephritis.

Authors:  A J Valdes; L B Senterfit; A D Pollack; F G Germuth
Journal:  Johns Hopkins Med J       Date:  1969-01

6.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

7.  Quantitation of acute and chronic serum sickness in the rabbit.

Authors:  C B Wilson; F J Dixon
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

8.  Properties of soluble immune complexes.

Authors:  R W Lightfoot; R E Drusin; C L Christian
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

9.  IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM.

Authors:  J H MORSE; C L CHRISTIAN
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  5 in total

Review 1.  Antibodies as carrier proteins.

Authors:  B N Rehlaender; M J Cho
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

2.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

3.  Specific autoantibody slows the rapid plasma clearance of 125I-SS-B (La) in mice.

Authors:  L Schrieber; R D Melsom; P J Venables; D A McCarthy; R N Maini
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

Review 4.  Vaccines for cocaine abuse.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Thomas R Kosten
Journal:  Hum Vaccin       Date:  2009-04-20

5.  Clearance of immune complexes formed in normal and leukaemic rats.

Authors:  P S Shepherd; R A Pendry; C J Dean
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.